SCHEMBL331785

SCHEMBL331785

CCCCCCCCCC(C=O)[Si](OCC)(OCC)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 1/20 0.34
SMPD1 P17405 3/20 0.34
MAPT P10636 2/20 0.34
TRPA1 O75762 1/20 0.34
DDAH1 O94760 1/20 0.34
GAPDH P04406 1/20 0.34
GPR84 Q9NQS5 3/20 0.33
FDPS P14324 3/20 0.33
ZDHHC7 Q9NXF8 1/20 0.33
FFAR1 O14842 1/20 0.33
TP53 P04637 1/20 0.32
LCK P06239 1/20 0.32
PPARD Q03181 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28676752 1.00 ADH1B (0.39) ADH1BADH1CADH1AADH4ADH7
SCHEMBL915310 0.98 ADH1B (0.38) ADH1BADH1CADH1AADH4ADH7
Ethylene Glycol SCHEMBL631056 0.85 ADH1B (0.33) ADH1BADH1CADH1AADH4ADH7
SCHEMBL22638056 0.84 ADH1B (0.38) ADH1BADH1CADH1AADH4ADH7
SCHEMBL4375644 0.83 ADH1B (0.40) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3910839 0.82 ADH1B (0.37) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3918478 0.82 ADH1B (0.37) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3908818 0.82 ADH1B (0.37) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3913385 0.81 ADH1B (0.36) ADH1BADH1CADH1AADH4ADH7
SCHEMBL3919931 0.81 ADH1B (0.36) ADH1BADH1CADH1AADH4ADH7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240393345-A1 Protein Capture Membrane and Method of Use Thereof UNIV YALE (US) 2024-11-28 US claimed
CN-111349555-B Digital PCR amplification device based on micropore array chip and use method thereof 成都万众壹芯生物科技有限公司 2023-07-18 CN claimed
US-20220403528-A1 COATED METAL ALLOY SUBSTRATE AND PROCESS FOR PRODUCTION THEREOF HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2022-12-22 US claimed
EP-4073290-A1 COATED METAL ALLOY SUBSTRATE AND PROCESS FOR PRODUCTION THEREOF Hewlett-Packard Development Company, L.P. (US) 2022-10-19 EP claimed
WO-2022075981-A1 FLUID-WICKING MEMBRANES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-04-14 WO claimed
WO-2021183115-A1 PROTECTIVE PANELS WITH ANTI-GLARE CERAMIC COATS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-09-16 WO claimed
US-20210188702-A1 ETCHED GLASS SURFACES WITH HYDROPHOBIC ALKOXYORGANOSILANES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-06-24 US claimed
WO-2021114015-A1 COATED METAL ALLOY SUBSTRATE AND PROCESS FOR PRODUCTION THEREOF HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-06-17 WO claimed
US-20210132077-A1 Protein Capture Membrane and Method of Use Thereof CONNECTICUT INNOVATIONS, INCORPORATED 2021-05-06 US claimed
EP-3814765-A1 PROTEIN CAPTURE MEMBRANE AND METHOD OF USE THEREOF Yale University (US) 2021-05-05 EP claimed
WO-2020055414-A1 ETCHED GLASS SURFACES WITH HYDROPHOBIC ALKOXYORGANOSILANES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2020-03-19 WO claimed
WO-2019217396-A1 PROTEIN CAPTURE MEMBRANE AND METHOD OF USE THEREOF YALE UNIVERSITY (US) 2019-11-14 WO claimed
WO-2019147714-A1 MICROFLUIDIC MICROARRAY DEVICES AND METHODS SHIELD DIAGNOSTICS CORP. (US) 2019-08-01 WO claimed
EP-1767188-B1 Cosmetic composition comprising an organic silicium compound and process for shaping hair OREAL (FR) 2014-03-05 EP claimed
US-8114679-B2 Optical biosensing platform utilizing nanocrystalline zinc oxide THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2012-02-14 US claimed
US-20090068755-A1 Optical biosensing platform utilizing nanocrystalline zinc oxide USA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2009-03-12 US claimed
US-20090022900-A1 METHOD FOR MANUFACTURING WIRE GRID DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2009-01-22 US claimed
US-20080226576-A1 Hair shaping compositions comprising at least one silicone and at least one alkoxysilane having solubilizing functional groups L'OREAL S.A. (FR) 2008-09-18 US claimed
EP-1935398-A1 Use of a silicone in a hair styling compositions including an alkoxysilane containing a functional group for making it soluble L'Oréal (FR) 2008-06-25 EP claimed
EP-1767188-A2 Cosmetic composition comprising an organic silicium compound and process for shaping hair L'OREAL (FR) 2007-03-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080226576-A1 Hair shaping compositions comprising at least one silicone and at least one alkoxysilane having solubilizing functional groups SHH, SMS, NACA ADH1B 3474/4885ADH1C 2321/4885ADH1A 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.